These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis. Oshima T, Wu L, Li M, Fukui H, Watari J, Miwa H. J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822 [Abstract] [Full Text] [Related]
27. Association of Clostridium difficile infections with acid suppression medications in children. Nylund CM, Eide M, Gorman GH. J Pediatr; 2014 Nov; 165(5):979-84.e1. PubMed ID: 25112692 [Abstract] [Full Text] [Related]
29. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study. Freedberg DE, Lamousé-Smith ES, Lightdale JR, Jin Z, Yang YX, Abrams JA. Clin Infect Dis; 2015 Sep 15; 61(6):912-7. PubMed ID: 26060292 [Abstract] [Full Text] [Related]
31. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN. Clin Ther; 2009 Sep 15; 31(9):2038-47. PubMed ID: 19843493 [Abstract] [Full Text] [Related]
33. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study. Leonard AD, Ho KM, Flexman J. Intern Med J; 2012 May 15; 42(5):591-4. PubMed ID: 22616966 [Abstract] [Full Text] [Related]
34. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection. Rodriguez S, Hernandez MB, Tarchini G, Zaleski M, Vatanchi M, Cardona L, Castro-Pavia F, Schneider A. Clin Gastroenterol Hepatol; 2014 Nov 15; 12(11):1856-61. PubMed ID: 24681079 [Abstract] [Full Text] [Related]
36. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. J Hosp Infect; 2008 Oct 15; 70(2):142-7. PubMed ID: 18723249 [Abstract] [Full Text] [Related]
37. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control. Marwick CA, Yu N, Lockhart MC, McGuigan CC, Wiuff C, Davey PG, Donnan PT. J Antimicrob Chemother; 2013 Dec 15; 68(12):2927-33. PubMed ID: 23825381 [Abstract] [Full Text] [Related]
39. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Hu MY, Katchar K, Kyne L, Maroo S, Tummala S, Dreisbach V, Xu H, Leffler DA, Kelly CP. Gastroenterology; 2009 Apr 15; 136(4):1206-14. PubMed ID: 19162027 [Abstract] [Full Text] [Related]
40. Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset. Kimura T, Snijder R, Sugitani T. J Infect Chemother; 2019 Aug 15; 25(8):615-620. PubMed ID: 30987950 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]